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Coronary artery diseaseObjectives: This study sought to investigate the clinical utility of aortic valve calcium score (AVCS) determined by
using cardiac multislice computed tomography (MSCT).
Methods: Data of 1315 consecutive patients who underwent both conventional echocardiography and MSCT
were reviewed. Degree of aortic stenosis (AS) was assessed according to mean pressure gradient (mPG) mea-
sured by echocardiography. Extent of coronary artery disease (CAD) derived by MSCT also was evaluated in
1173 patients who did not undergo prior coronary treatment. Both AVCS and coronary calcium score (CCS)
were deﬁned by Agatston units (AU) according to MSCT ﬁndings.
Results: A total of 613 of 1315 patients were deﬁned as AVCS positive (mean, 100 AU [range, 31.0–380.0 AU]).
AVCS showed signiﬁcant correlations with mPG (Spearman's ρ = 0.81, p b 0.001), and CCS (ρ = 0.53, p b
0.001). Differential adequate cut-off values of AVCS were proved for predicting severe AS with mPG
≥40 mmHg (1596.5 AU; AUC, 0.88; sensitivity, 89.7%; speciﬁcity, 77.0%), and for predicting moderate AS
with mPG ≥ 20 mmHg (886.5 AU; area under the curve [AUC], 0.91; sensitivity, 92.4%; speciﬁcity, 78.3%).
Mean AVCS was higher with increased extent of CAD (none, 0 AU [range, 0–30 AU]; single vessel, 8.5 AU
[range, 0–104 AU]; multivessel, 142 AU [range, 10–525 AU]; p b 0.001). The optimal cut-off value of AVCS
for predicting multivessel disease was 49 AU (AUC, 0.77; sensitivity, 68.8%; speciﬁcity, 78.0%).
Conclusions: AVCS might be a surrogate marker not only for AS grading but also for CAD progression. There-
fore, routine AVCS assessment could be useful for risk stratiﬁcation.
© 2015 Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Cardiac multislice computed tomography (MSCT) is a noninvasive
imaging modality that is widely used in the clinical ﬁeld for screening
patients with suspected cardiovascular disease [1]. MSCT ﬁndings pro-
vide information not only on coronary atherosclerotic burden but also
on precise cardiac structure [2,3]. Calcium score (CS) determined by
using MSCT enables quantitative evaluation of the degree of calciﬁca-
tion, as total volume of calcium deposition is considered to reﬂect
atherosclerotic change in each coronary artery, aortic valve, or aorta
[4–5]. Several previous clinical studies have demonstrated the.
is an open access article under the Cdiagnostic utility of aortic valve calcium score (AVCS) for grading of aor-
tic stenosis (AS) initially diagnosed by using echocardiography [6–7].
Recent interesting data proved that AVCS assessment showed new in-
sights regarding calciﬁedAS based on discordantmarkers of severity be-
tween aortic valve area (AVA) andmeanpressure gradient (mPG)when
combinedwith standard Doppler echocardiography [8]. The above ﬁnd-
ings support that AVCS determined by using MSCT is useful for screen-
ing patients in daily practice, though AVCS assessment is not routinely
recommended in the clinical ﬁeld. Diagnostic MSCT could be more use-
ful for detecting the severity of AS in addition to the existence of
coronary artery disease (CAD). However, the relationship between
CAD and AS based on CS derived by using MSCT has not been fully
clariﬁed. Therefore, in this study, the potential utility of AVCS assess-
ment was investigated in patients who underwent both MSCT and
echocardiography.C BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Between August 2013 and September 2014, 1315 consecutive pa-
tients underwent comprehensive MSCT and echocardiography within
a 1-month period for evaluation of cardiac disease at our center. Rea-
sons for undergoingdiagnosticMSCT and echocardiographywere as fol-
lows: (1) clinical symptoms, including chest pain, dyspnea on effort,
palpitation, pretibial edema, or other physiologic abnormality; (2) ex-
amination ﬁndings, including electrocardiographic abnormality, chest
radiographic abnormality, echocardiographic abnormality, elevation of
laboratory data including cardiac biomarker, or other abnormal result;
and (3) speciﬁc pretreatment preparation for percutaneous interven-
tion or cardiac surgery. All 1315 patients were enrolled for the initial
analysis concerning the relationship between AVCS and AS grading in
the overall cohort. For the second analysis concerning CAD, 203 patients
comprising 26who underwent coronary artery bypass grafting and 177
who underwent percutaneous coronary intervention were excluded.
The remaining 1112 patients who did not undergo prior coronary
treatment were evaluated regarding the relationship between
AVCS and CAD. This study had a retrospective, cross-sectional, obser-
vational design. The Medical Ethics Committee of Toyohashi Heart
Center (Toyohashi, Japan) approved the study protocol. Informed
consent was waived due to the retrospective nature of the study.
All patients were scanned using a 256-slice scanner (Brilliance iCT;
Philips Medical Systems, Eindhoven, The Netherlands) at the Toyohashi
Heart Center. Before MSCT angiography, a noncontrast MSCT scan was
performed to measure CS according to the modiﬁed Agatston method
[9–10]. Prospective electrocardiogram triggering (75% of R–R interval)
was used with a slice thickness of 2.5 mm. The scan was performed be-
tween the tracheal bifurcation and the diaphragm with the following
parameters: collimation width, 32 × 0.625 mm; rotation time, 330 ms;Fig. 1. A whole image of AVCS calculation by using MSCT was presented in panels A–B. Corres
annulus basal plane between the red lines. Three dotted lines correlated with each section w
was excluded from the analysis (panels F–H).tube voltage, 120 kV; and maximum effective tube current, 64 mA.
Image reconstruction was gated prospectively to 75% of R–R interval.
MSCT images were reconstructed using a cardiac standard ﬁlter with a
slice thickness of 2.5 mm. MSCT data sets were transferred to an ofﬂine
workstation (Intelli Space Portal; Philips Medical Systems) for image
analysis. MSCT data sets were transferred to an ofﬂine workstation
(Aquarius NetStation; Terarecon Inc., San Mateo, CA, USA) for image
analysis. AVCS and coronary calcium score (CCS) were determined
2-dimensionally by using the CS data sets on the workstation, and de-
ﬁned by Agatston units (AU). The AVCS area of interest comprised the
sinotubular junction (STJ), valve cusp, aortic annulus, and left ventricle
outﬂow tract; the start of acquisition was placed from the bottom of
the valve to the level of the STJ. A representative example of AVCS as-
sessment is shown in Fig. 1. CCS also was determined by summing the
individual lesion scores of each of the main coronary arteries based on
modiﬁed American Heart Association classiﬁcation; segments with a
diameter N 2.0 mm were analyzed. Luminal diameter stenosis was
assessed by visual estimation, with signiﬁcant stenosis deﬁned as
N50% stenosis. Structures N2 mm2 adjacent to the lumen that could be
distinguished from the lumen and the surrounding pericardial tissue
were deﬁned as coronary plaque, as we have previously shown. All
MSCT angiographic images were analyzed by 2 independent observers.
In the case of different observer readings, a consensus reading was per-
formed and used in the ﬁnal analysis.
A comprehensive M-mode echocardiogram was performed in all
patients by an experienced echocardiographic technician using a high-
quality commercially available ultrasonic system; 2-dimensional imag-
ingwas performed using integral pulsed and continuous wave Doppler.
Severity of AS (none, mild, moderate, severe) was classiﬁed based on
the American clinical guidelines for valvular heart disease [11]. The
current study deﬁned severe AS as mPG ≥ 40 mmHg or peakponding with each thin slice images, the AVCS area of interest included from STJ to aortic
ere given (panels C–E) and the AVCS calculated the other aorta or coronary calciﬁcation
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velocity ≥ 3.0 m/s. Several other parameters, including ejection fraction,
indexed AVA (AVA/body surface area), and peak velocity, also were
calculated.
All statistical analyses were performed using SPSS version 22 (SPSS
Inc., Chicago, IL, USA). AVCS and CCS values were expressed as median
(interquartile range) because of their skewed distribution. Other con-
tinuous variables were expressed as average ± SD, while categorical
datawere expressed as percentage of the total. Between-group compar-
isons were performed using Pearson's bivariate test and the χ2 test for
categorical covariates, and one-way analysis of variance for continuous
covariates. Comparisons of each parameter (e.g. AVCS, AVA, CCS) deter-
mined by using MSCT and echocardiography were analyzed by using
Spearman's correlation. Receiver operating characteristic (ROC) curve
analysis also was performed to examine the ability of each parameter
to identify subjects according to AS or CAD classiﬁcation. All statistical
tests were 2-sided, and p values of b0.05 were considered signiﬁcant.3. Results
Baseline clinical, echocardiographic, and MSCT ﬁndings of 1315
patients are presented in Table 1. Average estimated glomerular
ﬁltration rate (eGFR) was 66.8 ± 15.6 mL/min/1.73 m2; 388 pa-
tients (29.5%) were classiﬁed as having chronic kidney disease
(eGFR b 60mL/min/1.73m2). A total of 142 patients (10.8%)were diag-
nosed as having AS (mild to severe) on echocardiography. Prevalence of
patients who were deﬁned as AVCS positive (minimum, 1 AU; maxi-
mum, 6757 AU) on MSCT was 46.6% (n = 613). Of the 1112 patients
in whom extent of CAD was evaluated, 620 (55.8%) were deﬁned as
CCS positive (minimum, 0.2 AU; maximum, 4662 AU). A total of 157
(15.9%) of the 1112 patients were suspected to have CAD (single- to
3-vessel disease) based onMSCT ﬁndings. There was only a small num-
ber of patients with 3-vessel disease; thus, patients with 2-vessel
disease (n=51, 4.6%) and 3-vessel disease (n= 13, 1.2%) were catego-
rized as having multivessel disease (n = 64, 5.8%).Table 1
Baseline clinical characteristics.
Patients n = 1315
Baseline clinical characteristics
Age, years 65.3 ± 13.1
Gender (male) (52.2%)
Body mass index (kg/m2) 23.4 ± 3.8
Body surface area (m2) 1.6 ± 0.045
Diabetes mellitus, n 184 (14.0%)
Dyslipidemia, n 305 (23.2%)
Hypertension, n 550 (41.8%)
Smoking, n 258 (19.6%)
Chronic kidney disease, n 388 (29.5%)
Estimated glomerular ﬁltration rate (mL/min/1.73 m2) 66.8 ± 15.6
Echocardiographic data
Ejection fraction, % 63.3 ± 7.8
Degree of aortic stenosis
None-mild, n 1201 (91.3%)
Moderate, n 46 (3.5%)
Severe, n 68 (5.2%)
Aortic valve area (cm2) 1.2 ± 0.56
Indexed aortic valve area (cm2/m2) 0.78 ± 0.36
Mean gradient (mmHg) 26.1 ± 22.1
Peak velocity (m/s) 3.2 ± 1.4
Cardiac multidetector computed tomography data
Aortic valve calcium score (Agatston unit) 100 (31.0–380.0)
Coronary calcium score (Agatston unit) 307.2 (31.5–379.0)
Number of coronary artery disease (n = 1112)
None, n 921/1112 (82.8%)
Single vessel disease, n 113/1112 (10.2%)
Two vessel disease, n 51/1112 (4.6%)
Three vessel disease, n 13/1112 (1.2%)
Multi-vessel disease, n 64/1112 (5.8%)There were signiﬁcant correlations between AVCS and AVA
(Spearman's ρ=−0.78, p b 0.001), indexed AVA (ρ= 0.81, p b 0.001),
mPG (ρ= 0.81, p b 0.001), and peak aortic valve velocity (ρ= 0.81, p b
0.001). Those scatter plots are shown in Fig. 2. AVCS also showed a mild
positive correlation with CCS (ρ= 0.53, p b 0.001). When patients were
divided into 3 groups according to AS grade (none/mild [n = 1201],
moderate [n = 46], and severe [n = 68]), mean AVCS was higher
with increased severity of AS (0 AU [range, 0–40.3 AU], 498 AU
[range, 276–1318 AU], 2143 AU [range, 1577–3275 AU], respectively;
p b 0.001). When patients were divided into 3 groups according to
extent of CAD (none [n = 921], single-vessel disease [n = 113], and
multivessel disease [n = 64]), mean AVCS also was higher with in-
creased extent of CAD (3.2 AU [range, 0–134.6 AU], 255.5 AU [range,
0–1097.2 AU], 481.4 AU [range, 0.25–967.1 AU], respectively; p b 0.001).
ROC curve analysis indicated that the optimal threshold of AVCS for
predicting severe AS with mPG ≥ 40 mmHg was 1596.5 AU (area under
the curve [AUC], 0.88; 95% conﬁdence interval [CI], 0.81–0.93; sensitiv-
ity, 89.7; speciﬁcity, 77.0; p b 0.001), and for predicting moderate
AS with mPG ≥ 20 mmHg was 886.5 AU (AUC, 0.91; 95% CI, 0.84–0.95;
sensitivity, 92.4%; speciﬁcity, 78.3%; p b 0.001) (Fig. 3A). Another
optimal thresholds of AVCS for predicting severe AS with peak
velocity ≥ 4.0 m/s were 1574.0 AU (AUC, 0.91; 95% CI, 0.87–0.96; sensi-
tivity, 85.5%; speciﬁcity, 88.0%; p b 0.001), and for predicting moderate
AS with peak velocity ≥ 3.0 m/s was 793.0 AU (AUC, 0.90; 95% CI,
0.86–0.95; sensitivity, 90.4%; speciﬁcity, 75.6%; p b 0.001), and for
predicting AVA b 1.0 cm2 was 785.5 AU (AUC, 0.92; 95% CI, 0.88–0.96;
sensitivity, 92.4%; speciﬁcity, 81.6%; p b 0.001). In addition, the cut-off
value of AVCS for predicting single-vessel disease was 33 AU (AUC,
0.66; 95% CI, 0.63–0.68; sensitivity, 50.9%; speciﬁcity, 76.0%; p b
0.001), and for predicting multivessel disease was 49 AU (AUC, 0.77;
95% CI, 0.75–0.80; sensitivity, 68.8%; speciﬁcity, 78.0%; p b 0.001) (Fig.
3B).
4. Discussion
Although AVCS assessment is not routinely recommended during
MSCT examination, the current study demonstrated that it might be
useful for risk stratiﬁcation of both CAD and AS. Abundant calcium pro-
liferation is associated with progressive atherosclerotic stage. Local cal-
ciumquantiﬁcation according to CS of a coronary artery or aortic valve is
thought to be related to precise diagnosis or subsequent disease in an
individual patient [13–14]. There is general agreement that diagnosis
of AS should be based on echocardiographic ﬁndings, while previous
clinical studies have demonstrated the additional diagnostic value of
AVCS for AS grading [6–8]. In this study, the thresholds of AVCS for
predicting severe AS with mPG ≥ 40 mmHg and with peak
velocity ≥ 4 m/s were deﬁned as 1596.5 AU and 1574.0 AU, respec-
tively. Previous cut-off values of AVCS for predicting severe AS have
ranged from approximately 1200 to 2000 AU in similar to our data.
TheAVCSvalueof785.5AUwasalsooptimal for reﬂectingAVAb1.0cm2,
, while this cut-off valuewas found to be a little bit overestimatedwhen
considered as severe AS with AVA b 1.0 cm2 compared with other ﬁnd-
ings of mPG ≥ 40 mmHg or peak velocity ≥ 4.0 m/s. In addition, we
showed cut-off values of AVCS of 886.5 AU and 793.0 AU were optimal
for including moderate AS with mPG ≥ 20 mmHg and with peak
velocity ≥ 3.0 m/s. Recent interesting data proved that AVCS classiﬁca-
tion showed new insights regarding calciﬁed AS based on discordant
markers of severity between AVA and mPG (or peak velocity) when
combinedwith standard Doppler echocardiography [9]. It meant the dif-
ference betweenmoderate AS or low-ﬂow, low-gradient severe AS in the
same category with AVA b 1.0 cm2 and mPG ≤ 40 mmHg (or peak
velocity b 4.0 m/s). In general, dobutamine stress echocardiography is
useful for distinguishing between moderate AS and low-ﬂow, low-
gradient severe AS. However, the abovementioned cut-off values are
only a guide and should not be overstated comparedwith standard diag-
nostic echocardiographic criteria for AS grading. Nonetheless, patients
Fig. 2. The scatter plots presented the relationship between the AVCS and each echocardiographic parameters AVA (panel A), indexed AVA (panel B), mPG (panel C), and peak velocity
(panel D).
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ered to have borderline moderate-to-severe AS. Especially in patients
with calciﬁed AS, AVCS assessment may support diagnosis of AS in addi-
tion to conventional echocardiographic ﬁndings.
This study also clariﬁed the positive correlation between AVCS and
CCS, as well as the higher AVCS with increased extent of CAD. Our
results indicate that a possible threshold for detecting single-vessel dis-
ease is 33 AU, while that for detecting multivessel disease is 40 AU. It is
best to screen for both AS and CAD before invasive therapy, such as
percutaneous coronary intervention or cardiac surgery. For example,Fig. 3. The ROC curve used to determine the optimal cut-off value for severe or mcalciﬁed plaque in a coronary artery frequently requires rotational ath-
erectomy, and surgeons can be aware of any subsequent or coexisting
AS during the procedure to avoid unexpected hemodynamic instability.
Patients who have scheduled aortic valve replacement or coronary ar-
tery bypass grafting should be screened for CAD and AS, though they
are not routinely evaluated during MSCT examination. Calcium deposi-
tion in an aortic valve or coronary artery is thought to reﬂect systemic
atherosclerosis [4–5]. Thus, quantitative AVCS and CCS assessment
would be more informative for evaluating the degree of AS and CAD
derived by using MSCT. Quantitative AVCS assessment during cardiacoderate to severe AS (panel A), and single or multi vessel disease (panel B).
99K. Shimizu et al. / IJC Heart & Vasculature 9 (2015) 95–99MSCT is easily and rapidly evaluated not speciﬁc technique as we
shown. The above results may encourage physicians to evaluate not
only coronary calcium proliferation but also aortic valve calcium depo-
sition in the general population, though quantitative calcium scoring is
difﬁcult in non-cardiac MSCT examination.
Nonetheless, the following limitations apply to the current study.
First, this study had a retrospective, cross-sectional design, and did not
focus on prognosis. Second, the majority of patients with AS were cate-
gorized as having degenerated calciﬁed AS, reﬂecting the aging of soci-
ety; however, the etiology of AS is known to be multifactorial. The
diagnostic value of AVCS for AS gradingwould be attenuatedwhen con-
sidering rheumatic or non-calciﬁed origins of AS. Finally, although the
total sample size of the current study was relatively large, prevalence
of CAD and AS was low because MSCT examinations were performed
for several clinical purposes including screening.
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